norfluoxetine has been researched along with Colonic Diseases, Functional in 1 studies
norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation
Colonic Diseases, Functional: Chronic or recurrent colonic disorders without an identifiable structural or biochemical explanation. The widely recognized IRRITABLE BOWEL SYNDROME falls into this category.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine is an antidepressant that is administered as a racemic mixture of equipotent R- and S-enantiomers." | 2.70 | Effect of alosetron on the pharmacokinetics of fluoxetine. ( D'Souza, DL; Dimmitt, DC; Koch, KM; Nezamis, J; Robbins, DK; Simms, L, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Souza, DL | 1 |
| Dimmitt, DC | 1 |
| Robbins, DK | 1 |
| Nezamis, J | 1 |
| Simms, L | 1 |
| Koch, KM | 1 |
1 trial available for norfluoxetine and Colonic Diseases, Functional
| Article | Year |
|---|---|
Effect of alosetron on the pharmacokinetics of fluoxetine.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Biological Availability; Carb | 2001 |